Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · IEX Real-Time Price · USD
9.47
+0.62 (7.01%)
At close: May 16, 2024, 4:00 PM
9.53
+0.06 (0.63%)
After-hours: May 16, 2024, 7:31 PM EDT

Benitec Biopharma Statistics

Total Valuation

BNTC has a market cap or net worth of $86.09 million. The enterprise value is $76.85 million.

Market Cap 86.09M
Enterprise Value 76.85M

Important Dates

The last earnings date was Monday, May 13, 2024, before market open.

Earnings Date May 13, 2024
Ex-Dividend Date n/a

Share Statistics

BNTC has 9.37 million shares outstanding. The number of shares has increased by 58.95% in one year.

Shares Outstanding 9.37M
Shares Change (YoY) +58.95%
Shares Change (QoQ) +1.55%
Owned by Insiders (%) 10.42%
Owned by Institutions (%) 45.05%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 12,298.17
Forward PS n/a
PB Ratio 11.21
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 10,978.93
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.03.

Current Ratio 4.18
Quick Ratio 4.14
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -902.83

Financial Efficiency

Return on equity (ROE) is -175.40% and return on invested capital (ROIC) is -181.31%.

Return on Equity (ROE) -175.40%
Return on Assets (ROA) -127.80%
Return on Capital (ROIC) -181.31%
Revenue Per Employee $438
Profits Per Employee -$1.36M
Employee Count 16
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +155.39% in the last 52 weeks. The beta is 0.81, so BNTC's price volatility has been lower than the market average.

Beta (1Y) 0.81
52-Week Price Change +155.39%
50-Day Moving Average 6.40
200-Day Moving Average 4.00
Relative Strength Index (RSI) 66.04
Average Volume (30 Days) 91,496

Short Selling Information

Short Interest 98,532
Short Previous Month 12,221
Short % of Shares Out 1.05%
Short % of Float n/a
Short Ratio (days to cover) 0.49

Income Statement

In the last 12 months, BNTC had revenue of $7,000 and -$21.69 million in losses. Loss per share was -$0.07.

Revenue 7,000
Gross Profit 4,675
Operating Income -14.35M
Pretax Income -14.49M
Net Income -21.69M
EBITDA -14.25M
EBIT -14.47M
Loss Per Share -$0.07
Full Income Statement

Balance Sheet

The company has $9.47 million in cash and $236,427 in debt, giving a net cash position of $9.23 million or $0.99 per share.

Cash & Cash Equivalents 9.47M
Total Debt 236,427
Net Cash 9.23M
Net Cash Per Share $0.99
Equity / Book Value 7.68M
Book Value Per Share 0.82
Working Capital 7.30M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$13.49 million and capital expenditures -$119,549, giving a free cash flow of -$13.61 million.

Operating Cash Flow -13.49M
Capital Expenditures -119,549
Free Cash Flow -13.61M
FCF Per Share -$5.20
Full Cash Flow Statement

Margins

Gross margin is 66.79%, with operating and profit margins of -205,056.46% and -309,885.71%.

Gross Margin 66.79%
Operating Margin -205,056.46%
Pretax Margin -206,964.67%
Profit Margin -309,885.71%
EBITDA Margin -203,529.89%
EBIT Margin -206,735.68%
FCF Margin -194,484.96%

Dividends & Yields

BNTC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield -58.95%
Shareholder Yield -58.95%
Earnings Yield -25.20%
FCF Yield -15.81%
Dividend Details

Analyst Forecast

The average price target for BNTC is $16.00, which is 68.96% higher than the current price. The consensus rating is "Buy".

Price Target $16.00
Price Target Difference 68.96%
Analyst Consensus Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 446.13%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 26, 2023. It was a reverse split with a ratio of 1:17.

Last Split Date Jul 26, 2023
Split Type Reverse
Split Ratio 1:17

Scores

BNTC has an Altman Z-Score of 0.95 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 0.95
Piotroski F-Score 3